Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Oncol., 15 December 2025

Sec. Cancer Molecular Targets and Therapeutics

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1756715

Correction: Targeting PDCD4 in cancer and atrial fibrillation: mechanistic insights from integrated multi-omics and single-cell analysis

Juledezi HailatiJuledezi HailatiZhiqiang LiuZhiqiang LiuLei ZhangLei ZhangMuhuyati Wulasihan*Muhuyati Wulasihan*
  • Cardiovascular Disease Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

A Correction on
Targeting PDCD4 in cancer and atrial fibrillation: mechanistic insights from integrated multi-omics and single-cell analysis

By Hailati J, Liu Z, Zhang L and Wulasihan M (2025) Front. Oncol. 15:1593815. doi: 10.3389/fonc.2025.1593815

The reference for marker gene identification was erroneously written as “PMlD.3727811”. It should be “PMlD: 37440641”.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: atrial fibrillation, PDCD4, transcriptome sequencing, single-cell RNA sequencing, pan-cancer analysis

Citation: Hailati J, Liu Z, Zhang L and Wulasihan M (2025) Correction: Targeting PDCD4 in cancer and atrial fibrillation: mechanistic insights from integrated multi-omics and single-cell analysis. Front. Oncol. 15:1756715. doi: 10.3389/fonc.2025.1756715

Received: 02 December 2025; Accepted: 02 December 2025;
Published: 15 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Hailati, Liu, Zhang and Wulasihan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Muhuyati Wulasihan, bWh5dDU2N0AxNjMuY29t

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.